期刊文献+

罹患慢性荨麻疹与患者血清25-羟基维生素D3水平的关系

The relationship between the occurrence of chronic urticaria and the seru m level of 25-hydroxyvitamin D3
下载PDF
导出
摘要 目的:探讨慢性荨麻疹的发生与患者血清25-羟基维生素D3水平的关系。方法:采用酶联免疫吸附法(ELISA)对长治市第二人民医院门诊2018年2月至12月接诊的236例慢性荨麻疹患者(作为慢性荨麻疹组)和同期在该院接受体检的120例健康体检者(作为对照组)进行血清25-羟基维生素D3检测,然后比较两组人员血清25-羟基维生素D3的水平及其中维生素D缺乏者的占比。结果:1)慢性荨麻疹组患者血清25-羟基维生素D3的水平〔(42.35±3.52)nmol/L〕低于对照组体检者血清25-羟基维生素D3的水平〔(78.53±6.71)nmol/L〕,P<0.05。2)慢性荨麻疹组患者中维生素D缺乏者的占比(77.9%)高于对照组体检者中维生素D缺乏者的占比(51.7%),P<0.05。结论:慢性荨麻疹的发生与患者血清25-羟基维生素D3的水平较低密切相关。 Objective:To investigate the relationship between the occurrence of chronic urticaria and the serum level of 25-hydroxyvitamin D3.Methods:enzymelinked immunosorbent(ELISA)in changzhi city second people’s hospital outpatient service in February 2018 to December,accepts the 236 cases of patients with chronic urticaria(as chronic urticaria group)and in the same period in the healthy check-up of the 120 cases of medical examination at the hospital(as control)is used to detect the serum 25-hydroxy vitamin D3,then compared the two groups the levels of serum 25-hydroxy vitamin D3 and vitamin D deficiency in proportion.Results:1)The serum level of 25-hydroxyvitamin D3((42.35±3.52)nmol/L)in patients with chronic urticaria was lower than that in the control group((78.53±6.71)nmol/L),P<0.05.2)The proportion of patients with vitamin D deficiency in the chronic urticaria group(77.9%)was higher than that in the control group(51.7%),P<0.05.Conclusion:The occurrence of chronic urticaria is closely related to the low serum level of 25-hydroxyvitamin D 3.
作者 李慧 Li hui(Dermatology Department,The Second People’s Hospital of Changzhi,Changzhi 046000)
出处 《当代医药论丛》 2020年第19期1-2,共2页
关键词 慢性荨麻疹 血清 25-羟基维生素D3 Chronic urticaria Serum 25-hydroxyvitamin D3
  • 相关文献

参考文献4

二级参考文献45

  • 1张石革,宋菲,郝红兵.荨麻疹与抗过敏药[J].中国药房,2004,15(10):639-640. 被引量:1
  • 2张学军.皮肤病学[M].第5版,北京:人民卫生出版社,2001.95-97.
  • 3Oliver JM, Kepley CL, Ortega E, et al. lmmunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FcvarepsilonR1 signaling pathway. Immunopharmacology, 2000, 48 ( 3 ) : 269-281.
  • 4Hennino A, Berard F, Guillot I, et al. Pathophysiology of urticaria. Clin Rev Allergy Immunol, 2006, 30( 1 ) : 3-11.
  • 5Sabroe RA, Fiebiger E, Francis DM, et al. Classification of anti- FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol, 2002, 110 ( 3 ) : 492-499.
  • 6Ferrer M, Nakazawa K, Kaplan AP. Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol, 1999, 104( 1 ): 169-172.
  • 7Supajatura V, Ushio H, Nakao A, et al. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol, 2001, 167 (4): 2250-2256.
  • 8Miyajima I, Dombrowicz D, Martin TR, et al. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gamma RⅢ. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J Clin Invest, 1997, 99 (5): 901-914.
  • 9Malbec O, Fridman WH, Daeron M. Negative regulation of hematopoietic cell activation and proliferation by Fc gamma RIIB. Curt Top Microbiol Immunol, 1999, 244: 13-27.
  • 10Gauchat JF, Henchoz S, Mazzei G, et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature, 1993, 365 ( 6444 ) : 340-343.

共引文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部